Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:52 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 6,752 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Refractory Epilepsy, Epilepsy
Interventions: Exercise program, Health Coach, Health Information; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Memory Disorders, Cognitive Impairment
Interventions: Self-Guided, Structured Group; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 65 Years to 90 Years
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: E.Coli Infections, Bloodstream Infection
Interventions: SNIPR001, Placebo; Drug
Lead sponsor: SNIPR Biome Aps.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Lung Cancer
Interventions: AmDTx-PCSP, AmDTx-2048, Questionnaires; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Caregivers, Burnout, Sleep
Interventions: Mindfulness Training, Reappraisal Training; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 50 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Type1diabetes, Low Carbohydrate Diet
Interventions: low carbohydrate diet, standard carbohydrate diet; Other
Lead sponsor: Yale University; Other
Eligibility: 12 Years to 21 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Sedentary Behavior
Interventions: Behavioral Change Techniques; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 45 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Systemic Lupus Erythematosus, Physical Activity, Sleep
Interventions: Smartphone Application, Fitbit Activity Monitor, Coaching Sessions; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Diabetes Mellitus
Interventions: Technology-supported care; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 1,485 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 8
States / cities: El Monte, California • Lancaster, California • Long Beach, California + 4 more

Conditions: Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
Interventions: Bendamustine, Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Echocardiography, Fludarabine, Leukapheresis, Magnetic Resonance Imaging, Multigated Acquisition Scan, Positron Emission Tomography, T-cell Receptor-engineered T-cells; Drug · Procedure · Biological
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetic Retinopathy
Interventions: I-SITE; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Depression, Anxiety, Fatigue, Pain, Chronic, Sleep
Interventions: Modified yoga class; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 65 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Peritoneal Carcinomatosis
Interventions: Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC); Drug · Device
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Body Composition, Feeding; Difficult, Newborn, Nutrition Disorder, Infant
Interventions: Dietary intervention; Other
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 1 Week to 10 Weeks
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Orlando, Florida • Atlanta, Georgia

Conditions: High-Risk Oral Precancerous Disease
Interventions: RP2 Injection; Biological
Lead sponsor: Glenn J. Hanna; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory Myelodysplastic Syndrome
Interventions: NC525; Drug
Lead sponsor: NextCure, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 11
States / cities: Duarte, California • Miami, Florida • Boston, Massachusetts + 6 more

Conditions: Hyperparathyroidism, Primary
Interventions: 18F-Fluorocholine, Positron emission tomography (PET); Drug · Procedure
Lead sponsor: Thomas Hope; Other
Eligibility: 13 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pain, Chronic, Pain, Radiating, Pain, Back, Pain Syndrome
Interventions: Not listed
Lead sponsor: KM Clinical Research Group; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Murrieta, California

Conditions: Insomnia, Ulcerative Colitis
Interventions: CBT-I UC; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: oxaliplatin; Drug
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 11
States / cities: Los Angeles, California • Sacramento, California • Washington D.C., District of Columbia + 6 more

Conditions: Comparison of Non-invasive Monitors of Cardiac Function
Interventions: Not listed
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Sacramento, California

Conditions: KRAS Altered Advanced or Metastatic Solid Tumors
Interventions: AMG 410, Pembrolizumab, Panitumumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 434 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 10
States / cities: Duarte, California • Los Angeles, California • Atlanta, Georgia + 7 more

Conditions: Hemophilia A
Interventions: Emicizumab; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: Not listed
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 8
States / cities: Los Angeles, California • Palo Alto, California • Gainesville, Florida + 5 more

Conditions: Breast Cancer
Interventions: Collection of blood; Other
Lead sponsor: Sanford Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Fargo, North Dakota • Sioux Falls, South Dakota

Search by objective public record fields.

Exercise as Adjunctive Treatment for Refractory Epilepsy

Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention

A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects

A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung Cancer

Eudaimonia and Sleep: Effects of a Mindfulness Intervention in Caregivers of People With Dementia

Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes

Behavior Change Techniques (BCTs) to Improve Low Intensity Physical Activity in Older Adults

Activity and Nutrition Trial in Lupus to Energize and Renew

Diabetes-Depression Care-management Adoption Trial

T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer

I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study

Feasibility Study of a Modified Yoga Program for Elders

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty

Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease

A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Change in Pain and Quality of Life Following SCS for Chronic Pain

Piloting an Insomnia Treatment in Patients With Ulcerative Colitis

Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

Trendelenburg Study

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures

Autoantibodies in Breast Cancer Detection